𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Electrophysiological observations in idiopathic opsoclonus–myoclonus syndrome

✍ Scribed by Katrina A. Gwinn; Dr. John N. Caviness

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
467 KB
Volume
12
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

To supplement existing knowledge regarding the pathophysiology of the opsoclonus‐myoclonus syndrome, electrophysiological findings are reported in three patients with idiopathic opsoclonus–myoclonus. Surface electromyography (EMG) revealed <100‐ms synchronous discharges correlating with the clinical myoclonus. Short duration EMG discharges, with no back‐averaged cortical correlate, normal gross electroencephalogram, and no exaggerated responses with either evoked potential testing or long latency EMG responses were observed. The clinical and electrophysiological findings we describe are consistent with a brainstem origin of the myoclonus in this syndrome, with concurrent abnormalities in cerebellar circuits, similar to those described for paraneoplastic cases. The constellation of these electrophysiological findings differentiates the myoclonus in these patients from other clinical myoclonic entities.

📜 SIMILAR VOLUMES

Electrophysiological evidence of cerebra
Electrophysiological evidence of cerebral dysfunction in childhood opsoclonus-myoclonus syndrome
✍ Hiroshi Sakuma; Yuko Shimizu; Yoshiaki Saito; Kenji Sugai; Masumi Inagaki; Makik 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

A correct balance between endocannabinoid and dopamine-dependent systems is believed to underlie physiological motor control. We measured the levels of the endocannabinoid anandamide in the cerebrospinal fluid of Parkinson's disease (PD) patients. Subjects were divided into three groups: newly diagn

Autoantigen diversity in the opsoclonus-
Autoantigen diversity in the opsoclonus-myoclonus syndrome
✍ Luis Bataller; Myrna R. Rosenfeld; Francesc Graus; Juan J. Vilchez; Nai-Kong V. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

## Abstract Despite circumstantial evidence that opsoclonus‐myoclonus (OM) is often immune mediated, no specific autoantigen has been identified. Using sera of 21 patients with several types of OM (idiopathic, associated to small cell lung cancer, and associated to neuroblastoma), we probed a brain

Positive gallium scan in the syndrome of
Positive gallium scan in the syndrome of opsoclonus—myoclonus treated with adrenocorticotropic hormone
✍ Maria Gumbinas; Edward S. Gratz; Gerald S. Johnston; Allen D. Schwartz 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

The syndrome of opsoclonus and myoclonus may be the first presenting symptom of neuroblastoma. The disorder is often controlled by treatment with adrenocorticotropic hormone (ACTH). A child with this disorder and treated with ACTH gel had abnormal uptake of 67Ga in both adrenal glands during studies

CSF B-cell expansion in opsoclonus-myocl
CSF B-cell expansion in opsoclonus-myoclonus syndrome: A biomarker of disease activity
✍ Michael R. Pranzatelli; Anna L. Travelstead; Elizabeth D. Tate; Tyler J. Allison 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract Lack of a biomarker of disease activity has hindered the therapy of childhood opsoclonus‐myoclonus syndrome (OMS), which is purported to be mediated humorally. To determine if the cerebrospinal fluid (CSF) B lymphocyte, which may traffic into the central nervous system (CNS) to produce